NEW YORK, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Corcept Theraepeutics Incorporated (NASDAQ: CORT)?Did you lose money in your investment in Corcept Theraepeutics Incorporated?Do you want to discuss your rights? Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, is investigating whether Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NASDAQ: CORT) violated federal securities laws. If you own Corcept stock and would lik ...

股价表现与市场活动 - 公司当前股价为39.22美元，单日上涨5.66%或2.10美元 [3] - 公司股票当日交易区间在37.22美元至39.33美元之间，过去52周最高价为51.45美元，最低价为27.66美元 [3] - 公司当日交易量为3854万股，显示出活跃的市场参与度 [4] 分析师观点与估值 - RBC Capital为公司设定了48美元的目标价，暗示较当前股价有22.39%的潜在上行空间 [1][5] - 公司当前市值约为563.1亿美元 [4] 法律与监管动态 - Rosen Law Firm已对公司展开调查，涉及公司可能向公众提供了误导性商业信息的指控 [2][5]